Researchers have unlocked secrets of our ancient immune system, a major scientific advance which could help scientists and clinicians in the global fight against disease. An international team, including researchers from The University of Queensland, identified interactions between immune system pathways which could improve the treatment of diseases such as inflammatory bowel disease (IBD), which affects millions of people worldwide.

IMB staff have been recognised for their outstanding contributions to the UQ community at the 2016 UQ Awards for Excellence ceremony, held on 9 June.

IMB Research Grants Manager Michelle Foley received a UQ Award for Excellence in Service, and IMB’s Community for Antimicrobial Drug Discovery (CO-ADD) team received a UQ Award for Excellence in Innovation.

IMB Group Leader Dr Joseph Powell has been awarded the prestigious Commonwealth Health Minister’s Award for Excellence in Health and Medical Research.

Queensland researchers have made a big leap forward in their quest to eradicate the billions of cane toads wreaking havoc on our native wildlife and habitats.

Environmentally friendly cane toad traps – developed by a team of researchers from The University of Queensland and The University of Sydney – are one step closer to production, following an agreement between UQ and US-based pest control company, SpringStar Inc.

Spiders have helped researchers from Australia and the US discover a new target for irritable bowel syndrome pain.

Taking medicine in the future could be as simple as eating a sunflower seed or drinking a cup of tea made from herbs grown in your own garden.

An international team involving University of Queensland researchers has used advanced genome sequencing to diagnose 30 patients with unresolved rare diseases.

Join leading clinical pain scientist, Professor Lorimer Moseley, and IMB researchers as they discuss how the challenging and personal nature of pain is inspiring a new generation of patient-focused treatments for one of the most poorly understood and undertreated conditions in modern medicine.

UQ’s Community for Open Antimicrobial Drug Discovery (CO-ADD) has signed a Memorandum of Understanding (MOU) with the African Network for Drugs and Diagnostics Innovation (ANDI) which is hosted by the United Nations Office for Project Services (UNOPS).